Sort
78,016 grants matching “breast cancer”
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities
$1,189,690Lois B. Travis · University Of Rochester · R01 · FY2014 · CA
Loma Linda University Center for Health Disparities Research
$1,189,633Marino De Leon · Loma Linda University · P20 · FY2016 · MD
South Carolina Cancer Disparities Research Center (SC CADRE)
$1,189,540Marvella Elizabeth Ford · Medical University Of South Carolina · U54 · FY2021 · CA
MODULATING THE BREAST MICROBIOME TO PREVENT ER+ BREAST CANCER
$1,189,479Wake Forest University Health Sciences · · FY2020 · Defense Health Agency
PDX Core
$1,189,380Michael M. Ittmann · Baylor College Of Medicine · U54 · FY2018 · CA
Targeting the MET Pathway in Urothelial Carcinoma
$1,189,328Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Center of Excellence for Health Disparties in the Nation's Capital
$1,189,311Lucile L Adams-Campbell · Georgetown University · P60 · FY2013 · MD
Nuclear Structure and Gene Expression
$1,189,273Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2009 · CA
Identification of Inhibitors of Protein Sumoylation
$1,189,045John Schneekloth · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Novel Markers for Disease Outcome in Breast Cancer
$1,188,833Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
ANCESTRY-DEPENDENT STROMAL CELL FACTORS IN BREAST CANCER PROGRESSION
$1,188,750Trustees Of Indiana University · · FY2025 · Defense Health Agency
MAPK4 DEFINES A SUBSET OF TRIPLE-NEGATIVE BREAST CANCER VULNERABLE TO NOVEL TARGETED THERAPY
$1,188,750Baylor College Of Medicine · · FY2017 · Department of the Army
PREVENTION OF METASTATIC BREAST CANCER WITH A TLR5 AGONIST
$1,188,600Health Research, Inc. · · FY2015 · Department of Defense
Treg-depleting immunotherapy
$1,188,595Peter David Suzdak · Sonoval Llc · R44 · FY2021 · CA
EXPLOITING A NEW ACHILLES' HEEL OF MUTANT P53 IN BREAST CANCER
$1,188,554Baylor College Of Medicine · · FY2018 · Defense Health Agency
Photoacoustic / Optical / Ultrasonic Imaging of Sentinel Lymph Nodes and Metastas
$1,188,350Lihong Wang · Washington University · U54 · FY2010 · CA
TARGETING DDR1 ABERRATIONS IN METASTATIC ER+ BREAST CANCER
$1,188,155Baylor College Of Medicine · · FY2018 · Defense Health Agency
MEMBRANE TRAFFIC IN NORMAL AND TRANSFORMED CELLS
$1,188,028Yale University · P01 · FY2000 · CA
Long-term Survivorship in Older Women with Early Stage Breast Cancer
$1,187,507Rebecca A Silliman · Boston Medical Center · R01 · FY2010 · CA
Cancer cell adaptation to metabolic stress
$1,187,477M. Celeste Simon · University Of Pennsylvania · P01 · FY2012 · CA
PDX Trial Center for Breast Cancer Therapy
$1,187,139Alana L Welm · University Of Utah · U54 · FY2023 · CA
Genetic Epidemiology of Lung Cancer
$1,186,696Marshall W Anderson · University Of Cincinnati · U01 · FY2006 · CA
THE ROLE OF THE PHOSPHATIDYLINOSITOL-5-PHOSPHATE 4-KINASES IN P53 NULL BREAST CANCERS
$1,186,500Weill Medical College Of Cornell University · · FY2014 · Department of the Army
A NEOEPITOPE SUBUNIT VACCINE TARGETING THE MUTATED ESTROGEN RECEPTOR LIGAND BINDING DOMAIN TO TREAT AND PREVENT ENDOCRINE-RESISTANT ER+BREAST CANCER
$1,185,939Duke University · · FY2018 · Defense Health Agency
Myeloid TGFbeta signaling in breast cancer metastasis and dormancy
$1,185,828Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA